Xiamen Amoytop Biotech Co.,Ltd.’s Net Profit Rose 56.9% in First Three Quarters of 2022

Xiamen Amoytop Biotech Co.,Ltd. (厦门特宝生物工程股份有限公司) (688278.SH) reported a net profit of 200.4 million yuan in the first three quarters of 2022, up 56.9% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 41.2% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 297.7 million yuan in total liabilities, with a liability-to-asset ratio of 18.4%.